|
|
Article: Aphios Gets NIH Grant for CFI Virus and Pathogen Inactivation Technology.
- Article from:
- Health & Beauty Close-Up
- Article date:
- August 8, 2009
CopyrightCOPYRIGHT 2009 Close-Up Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Aphios Corp. announced that it has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Heart Lung and Blood Institute (NHLBI), National Institutes of Health (NIH) to develop CFI as a generally-applicable virus and pathogen inactivation technology for human plasma, plasma products and biologics.
In a release, the Company noted:
The recent outbreaks of potentially pandemic strains of influenza such as the H1N1 swine flu and the H5N1 bird flu, the worldwide AIDS epidemic, the emergence of West Nile virus and Babesia spp, and the periodic emergence of Ebola and SARS as well as the bioterrorism potential have highlighted a ...